Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents

Biomaterials

Volumn 53, Issue , 2015, Pages 349-357

  Wang, Xia ^a   Niu, Dechao ^b   Wu, Qing ^a   Bao, Song ^a   Su, Teng ^a   Liu, Xiaohang ^c   Zhang, Shengjian ^c   Wang, Qigang ^a  

^a TONGJI UNIVERSITY   (China)

^b East China University of Science and Technology   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Acid responsive; Magnetic resonance imaging; Manganese species; Nanogel; Superparamagnetic iron oxide particles

Indexed keywords

MAGNETIC RESONANCE IMAGING; MANGANESE COMPOUNDS; NANOSTRUCTURED MATERIALS; RESONANCE; SUPERPARAMAGNETISM; TUMORS;

ACIDIC ENVIRONMENT; HYBRID NANOGELS; MAGNETIC RESONANCE CONTRAST AGENTS; MANGANESE SPECIES; NANOGELS; PH RESPONSIVENESS; PROOF OF CONCEPT; SUPERPARAMAGNETIC IRON OXIDES;

IRON OXIDES;

IRON OXIDE; MANGANESE OXIDE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; CONTRAST MEDIUM; FERRIC ION; FERRIC OXIDE; GEL; MANGANESE DERIVATIVE; OXIDE;

ARTICLE; CANCER CELL CULTURE; CYTOTOXICITY; HUMAN; HUMAN CELL; HYDRODYNAMICS; HYDROGEL; IN VITRO STUDY; LIVER CELL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; POLYMERIZATION; PRIORITY JOURNAL; SCANNING TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; FEMALE; GEL; HEPG2 CELL LINE; MOUSE; NANOTECHNOLOGY; NUDE MOUSE;

ANIMALS; CONTRAST MEDIA; FEMALE; FERRIC COMPOUNDS; GELS; HEP G2 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE IMAGING; MANGANESE COMPOUNDS; MICE; MICE, NUDE; NANOTECHNOLOGY; OXIDES;

EID: 84927950782     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.02.101     Document Type: Article

References (44)

1. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005, 5:161-171.
2. Xie J., Liu G., Eden H.S., Ai H., Chen X.Y. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Accounts Chem Res 2011, 44:883-892.
3. Major J.L., Meade T.J. Bioresponsive, cell-Penetrating, and multimeric MR contrast agents. Accounts Chem Res 2009, 42:893-903.
4. Terreno E., Delli Castelli D., Viale A., Aime S. Challenges for molecular magnetic resonance imaging. Chem Rev 2010, 110:3019-3042.
5. Hasserodt J., Kolanowski J.L., Touti F. Magnetogenesis in water induced by a chemical analyte. Angew Chem Int Ed 2014, 53:60-73.
6. Choi J.S., Lee J.H., Shin T.H., Song H.T., Kim E.Y., Cheon J. Self-confirming "AND" logic nanoparticles for fault-free MRI. JAm Chem Soc 2010, 132:11015-11017.
7. Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater 2009, 21:2133-2148.
8. Cheon J., Lee J.H. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Accounts Chem Res 2008, 41:1630-1640.
9. McCarthy J.R., Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008, 60:1241-1251.
10. Gao J.H., Gu H.W., Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Accounts Chem Res 2009, 42:1097-1107.
11. Li Z., Yi P.W., Sun Q., Lei H., Zhao H.L., Zhu Z.H., et al. Ultrasmall water-soluble and biocompatible magnetic iron oxide nanoparticles as positive and negative dual contrast agents. Adv Funct Mater 2012, 22:2387-2393.
12. Niu D.C., Luo X.F., Li Y.S., Liu X.H., Wang X., Shi J.L. Manganese-loaded dual-mesoporous silica spheres for efficient T1- and T2-weighted dual mode magnetic resonance imaging. Acs Appl Mater Inter 2013, 5:9942-9948.
13. Klemm P.J., Floyd W.C., Smiles D.E., Frechet J.M.J., Raymond K.N. Improving T1 and T2 magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes. Contrast Media Mol I 2012, 7:95-99.
14. Zhou Z.J., Huang D.T., Bao J.F., Chen Q.L., Liu G., Chen Z., et al. Asynergistically enhanced T1-T2 dual-modal contrast agent. Adv Mater 2012, 24:6223-6228.
15. Nayak S., Lyon L.A. Soft nanotechnology with soft nanoparticles. Angew Chem Int Ed 2005, 44:7686-7708.
16. Kabanov A.V., Vinogradov S.V. Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew Chem Int Ed 2009, 48:5418-5429.
17. Sasaki Y., Akiyoshi K. Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications. Chem Rec 2010, 10:366-376.
18. Oh J.K., Drumright R., Siegwart D.J., Matyjaszewski K. The Development of microgels/nanogels for drug delivery applications. Prog Polym Sci 2008, 33:448-477.
19. Raemdonck K., Demeester J., De Smedt S. Advanced nanogel engineering for drug delivery. Soft Matter 2009, 5:707-715.
20. Karg M., Hellweg T. Smart inorganic/organic hybrid microgels: synthesis and characterisation. JMater Chem 2009, 19:8714-8727.
21. Nochi T., Yuki Y., Takahashi H., Sawada S., Mejima M., Kohda T., et al. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater 2010, 9:572-578.
22. Appel E.A., Loh X.J., Jones S.T., Biedermann F., Dreiss C.A., Scherman O.A. Ultrahigh-water-content supramolecular hydrogels exhibiting multistimuli responsiveness. JAm Chem Soc 2012, 134:11767-11773.
23. Li J.Y., Li X.M., Kuang Y., Gao Y., Du X.W., Shi J.F., et al. Self-delivery multifunctional anti-HIV hydrogels for sustained release. Adv Healthc Mater 2013, 2:1586-1590.
24. Morris K.L., Chen L., Raeburn J., Sellick O.R., Cotanda P., Paul A., et al. Chemically programmed self-Sorting of gelator networks. Nat Commun 2013 1480, 4.
25. Foreword Pelton R. Hydrogel micro and nanoparticles 2012, Wiley-VCH, Weinheim, p. XX-XXI. L.A. Lyon, M.J. Serpe (Eds.).
26. Courant T., Roullin V.G., Cadiou C., Callewaert M., Andry M.C., Portefaix C., et al. Hydrogels incorporating GdDOTA: towards highly efficient dual T1/T2 MRI contrast agents. Angew Chem Int Ed 2012, 51:9119-9122.
27. 4 (M=Fe, Co, Mn) nanoparticles. JAm Chem Soc 2004, 126:273-279.
28. Hollmann F., Arends I.W.C.E. Enzyme initiated radical polymerizations. Polymers 2012, 4:759-793.
29. Silva A.C., Lee J.H., Aoki L., Koretsky A.R. Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed 2004, 17:532-543.
30. Du J.Z., Sun T.M., Song W.J., Wu J., Wang J.A. Tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery. Angew Chem Int Ed 2010, 49:3621-3626.
31. Lowe M.P. MRI contrast agents: the next generation. Aust J Chem 2002, 55:551-556.
32. Pablico-Lansigan M.H., Hickling W.J., Japp E.A., Rodriguez O.C., Ghosh A., Albanese C., et al. Magnetic nanobeads as potential contrast agents for magnetic resonance imaging. Acs Nano 2013, 7:9040-9048.
33. 3 nanoparticles. Ifmbe Proc 2009, 25:537-540.
34. Shin J.M., Anisur R.M., Ko M.K., Im G.H., Lee J.H., Lee I.S. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew Chem Int Ed 2009, 48:321-324.
35. Kim T., Cho E.J., Chae Y., Kim M., Oh A., Jin J., et al. Urchin-shaped manganese oxide nanoparticles as pH-responsive activatable T1 contrast agents for magnetic resonance imaging. Angew Chem Int Ed 2011, 50:10589-10593.
36. Bennewitz M.F., Lobo T.L., Nkansah M.K., Ulas G., Brudvig G.W., Shapiro E.M. Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI. Acs Nano 2011, 5:3438-3446.
37. Chen Y., Yin Q., Ji X.F., Zhang S.J., Chen H.R., Zheng Y.Y., et al. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. Biomaterials 2012, 33:7126-7137.
38. 4/MnO hybrid nanocrystals as a dual contrast agent for both T1- and T2-weighted liver MRI. Biomaterials 2013, 34:2069-2076.
39. Brooks R.A., Moiny F., Gillis P. On T2-shortening by weakly magnetized particles: the chemical exchange model. Magn Reson Med 2001, 45:1014-1020.
40. Tong S., Hou S.J., Zheng Z.L., Zhou J., Bao G. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett 2010, 10:4607-4613.
41. 4 nanoparticles trapped in a porous silicon nanoparticle host. Adv Mater 2011, 23:H248-H253.
42. Zhao Z.H., Zhou Z.J., Bao J.F., Wang Z.Y., Hu J., Chi X.Q., et al. Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging. Nat Commun 2013, 4:2266.
43. Lu J., Ma S.L., Sun J.Y., Xia C.C., Liu C., Wang Z.Y., et al. Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging. Biomaterials 2009, 30:2919-2928.
44. Ba-Ssalamah A., Uffmann M., Saini S., Bastati N., Herold C., Schima W. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 2009, 19:342-357.